ArticleCancer biology & therapy2023

PLK4 inhibitor exhibits antitumor effect and synergizes sorafenib via arresting cell cycle and inactivating Wnt/β-catenin pathway in anaplastic thyroid cancer.

Wei Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.